---
title: CROs offering Pathology & Histology Services with Gene Therapy
path: /explore/pathology-histology/gene-therapy
companies_count: 8
---

# CROs offering Pathology & Histology Services with Gene Therapy

8 published CROs match Pathology & Histology Services and Gene Therapy.

Locations in this set include United States, China, Belgium, Global, India, and Netherlands.

Capabilities that show up most often in this set: In Vivo Efficacy Models, Preclinical In Vivo Studies, In Vivo PK / PD Studies, Preclinical In Vitro Studies, and Specialized & Large-Animal Models.

## Matching companies

- [Crown Bioscience](/companies/crownbio)
  - Preclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
- [Frontage Laboratories](/companies/frontagelab)
  - Global pharmaceutical development organization offering integrated drug discovery, preclinical safety/toxicology, DMPK, bioanalytical, and clinical trial services across 28 sites with 2,200 employees and 200+ FDA inspections.
- [InnoSer Laboratories](/companies/innoserlaboratories)
  - Preclinical CRO offering GLP and non-GLP toxicology, custom genetically modified mouse models, and disease models across oncology, neurology, immunology, metabolic, and cardiovascular research. Supports programs from target discovery through IND-enabling studies.
- [Inotiv](/companies/inotivco)
  - Inotiv provides integrated preclinical and safety assessment services including toxicology, bioanalysis, pathology, and specialized research models across discovery through IND-enabling phases.
- [Labcorp](/companies/labcorp)
  - Labcorp is a global life sciences and healthcare company providing diagnostic testing, drug development, nonclinical research, central laboratory services, and real-world data solutions to healthcare providers, health systems, and biopharma companies.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [VIRSCIO](/companies/virscio)
  - Virscio is a preclinical CRO offering non-human primate studies, histopathology, and molecular biology services. It supports IND-enabling efficacy, safety, and PK/PD programs in CNS, ophthalmology, and cardiometabolic areas.